The American Academy of Sleep Medicine (AASM) has updated its guidelines for the treatment of restless legs syndrome (RLS) for the first time in 12 years. In this video interview, guideline author ...

Typically, the first step in treating restless legs syndrome (RLS) is to identify the cause. Common causes of RLS can include daily habits, side effects of medications, and underlying health ...

RLS (Release Layer System) – a new, patented technology that reduces concussion risk by enabling panels on the exterior of a helmet to roll and release upon impact – has launched, with the Canyon ...

A new helmet technology called RLS (Release Layer System) is said to reduce the risk of concussion by four times, on average, compared with conventional helmets. With roughly 55 million cases of ...

A layer of foam may be good at protecting you from simple whacks on the head, but it's not necessarily sufficient when you're cycling at speed. That's where RLS bike helmet tech comes in. It's claimed ...

A brand new helmet technology called RLS, which stands for Release Layer System, has been launched today, promising to dramatically reduce the risk of concussion in head impacts. Something any cyclist ...

Attention all mayors! There's a heck of a lot of city builders headed our way, and as luck would have it, a whopping eight of them are coming in September alone. In fact, there are two you can play ...

A study finds a link between chronic kidney disease and Restless Legs Syndrome. RLS affects many CKD patients, especially those on dialysis. Iron deficiency is a key factor. Symptoms include an urge ...

The 2025 AASM guidelines recommend iron supplementation as the first-line treatment for RLS when ferritin levels are below 75 ng/mL. Dopamine agonists like ropinirole can reduce RLS symptoms but carry ...

Engaging in regular physical activity, approaches such as yoga or swimming, and specific stretches may reduce symptoms of restless leg syndrome (RLS), support better sleep, and improve quality of life ...

First patient dosed with topical RLS-1496 in clinical trial will assess the safety and clinical effects of single and multiple doses to treat adults with mild to moderate and stable plaque psoriasis, ...